Heterogeneity in Colorectal Primary Tumor and Synchronous Liver Metastases


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Тек жазылушылар үшін

Аннотация

The expression profile of the ZEB1, ZEB2, VIM, CDH1, SFRP2, FOXQ1, TNC, MACC1, PLS3, CFTR, FLNA, MUC2, TFF3, and RARRES3 genes, as well as the mutational status of the KRAS, NRAS, BRAF, and PIK3CA genes, were investigated in 40 patients with colorectal cancer and liver metastases. A comparative analysis of changes in gene expression in primary tumor cells and liver metastases was performed. Statistically significant differences were found between the expression levels of the ZEB2 (p = 0.004), VIM (p < 0.001), FLNA (p = 0.04), and MUC2 (p < 0.001) genes. It was demonstrated that the overall frequency of mutations of the KRAS gene was 18/40 (45%) and the PIK3CA gene was 9/40 (23%). Mutations in the NRAS and BRAF genes were not found. The concordance between the primary tumor and metastases in the liver by mutation status was 100%.

Авторлар туралы

V. Shubin

State Scientific Centre of Coloproctology

Хат алмасуға жауапты Автор.
Email: shwit@mail.ru
Ресей, Moscow, 123423

A. Ponomarenko

State Scientific Centre of Coloproctology

Email: shwit@mail.ru
Ресей, Moscow, 123423

A. Tsukanov

State Scientific Centre of Coloproctology

Email: shwit@mail.ru
Ресей, Moscow, 123423

O. Maynovskaya

State Scientific Centre of Coloproctology

Email: shwit@mail.ru
Ресей, Moscow, 123423

E. Rybakov

State Scientific Centre of Coloproctology

Email: shwit@mail.ru
Ресей, Moscow, 123423

M. Panina

State Scientific Centre of Coloproctology

Email: shwit@mail.ru
Ресей, Moscow, 123423

V. Kashnikov

State Scientific Centre of Coloproctology

Email: shwit@mail.ru
Ресей, Moscow, 123423

S. Frolov

State Scientific Centre of Coloproctology

Email: shwit@mail.ru
Ресей, Moscow, 123423

Yu. Shelygin

State Scientific Centre of Coloproctology

Email: shwit@mail.ru
Ресей, Moscow, 123423

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML

© Pleiades Publishing, Inc., 2018